JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fletcher, D. S.
Right arrow Articles by Visco, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fletcher, D. S.
Right arrow Articles by Visco, D.

Vol. 284, Issue 2, 714-721, February 1998

Therapeutic Administration of a Selective Inhibitor of Nitric Oxide Synthase Does Not Ameliorate the Chronic Inflammation and Tissue Damage Associated with Adjuvant-Induced Arthritis in Rats

Daniel S. Fletcher, W. Richard Widmer1, Silvi Luell, Amy Christen, Chad Orevillo, Shrenik Shah and Denise Visco

Departments of Pharmacology and Medicinal Chemistry, Merck & Co., Rahway, New Jersey

Up-regulation of the inducible isoform of nitric oxide synthase (iNOS) was determined during the development of adjuvant-induced arthritis in the rat. iNOS enzymatic activity, measured in spleen tissue, appeared and increased coincidentally with the appearance and degree of paw swelling and joint destruction in this arthritis model, when measured on days 0 through 21 subsequent to inoculation of the rats with adjuvant. The increase in enzymatic activity was paralleled by an increase in the plasma nitrite/nitrate (NOx) level and the appearance of immunoreactive iNOS, as measured by Western immunoblot, in the spleens of these rats. Prophylactic administration of N-iminoethyl-L-lysine (L-NIL) completely abolished iNOS activity (plasma NOx elevation) and effectively reduced both the swelling and radiographic changes in the joint tissues of the noninjected paw measured on day 21. However, therapeutic administration of L-NIL beginning on day 14 had no effect on the inflammatory or arthritic changes measured on day 21, even though plasma NOx levels were reduced to that of the naive controls. These results suggest that iNOS may be involved with the initial stages of the immune response to adjuvant injection, but its product, NO, does not mediate the chronic inflammation and joint destruction which occur during the later phase in this model.

0022-3565/98/2842-0714$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
K. Santora, C. Rasa, D. Visco, B. G. Steinetz, and C. A. Bagnell
Antiarthritic Effects of Relaxin, in Combination with Estrogen, in Rat Adjuvant-Induced Arthritis
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 887 - 893.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
P. Pacher, J. S. Beckman, and L. Liaudet
Nitric Oxide and Peroxynitrite in Health and Disease
Physiol Rev, January 1, 2007; 87(1): 315 - 424.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Claveau, M. Sirinyan, J. Guay, R. Gordon, C.-C. Chan, Y. Bureau, D. Riendeau, and J. A. Mancini
Microsomal Prostaglandin E Synthase-1 Is a Major Terminal Synthase That Is Selectively Up-Regulated During Cyclooxygenase-2-Dependent Prostaglandin E2 Production in the Rat Adjuvant-Induced Arthritis Model
J. Immunol., May 1, 2003; 170(9): 4738 - 4744.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Ohtsuka, F. Konno, H. Honda, T. Oikawa, M. Ishikawa, N. Iwase, K. Isomae, F. Ishii, H. Hemmi, and S. Sato
PPA250 [3-(2,4-Difluorophenyl)-6-{2-[4-(1H-imidazol-1-ylmethyl) Phenoxy]ethoxy}-2-phenylpyridine], a Novel Orally Effective Inhibitor of the Dimerization of Inducible Nitric-Oxide Synthase, Exhibits an Anti-Inflammatory Effect in Animal Models of Chronic Arthritis
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 52 - 57.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
A. Veihelmann, A. Hofbauer, F. Krombach, M. Dorger, M. Maier, H.-J. Refior, and K. Messmer
Differential function of nitric oxide in murine antigen-induced arthritis
Rheumatology, May 1, 2002; 41(5): 509 - 517.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. I. Boullerne, J. J. Rodriguez, T. Touil, B. Brochet, S. Schmidt, N. D. Abrous, M. Le Moal, J. R. Pua, M. A. Jensen, W. Mayo, et al.
Anti-S-Nitrosocysteine Antibodies Are a Predictive Marker for Demyelination in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis
J. Neurosci., January 1, 2002; 22(1): 123 - 132.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
Y Ersoy, E Ozerol, O Baysal, I Temel, R S MacWalter, U Meral, and Z E Altay
Serum nitrate and nitrite levels in patients with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis
Ann Rheum Dis, January 1, 2002; 61(1): 76 - 78.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
U. Reuter, H. Bolay, I. Jansen-Olesen, A. Chiarugi, M. S. del Rio, R. Letourneau, T. C. Theoharides, C. Waeber, and M. A. Moskowitz
Delayed inflammation in rat meninges: implications for migraine pathophysiology
Brain, December 1, 2001; 124(12): 2490 - 2502.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
D. Riendeau, M. D. Percival, C. Brideau, S. Charleson, D. Dubé, D. Ethier, J.-P. Falgueyret, R. W. Friesen, R. Gordon, G. Greig, et al.
Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 558 - 566.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
N. L. McCartney-Francis, X.-y. Song, D. E. Mizel, and S. M. Wahl
Selective Inhibition of Inducible Nitric Oxide Synthase Exacerbates Erosive Joint Disease
J. Immunol., February 15, 2001; 166(4): 2734 - 2740.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. A. Detmers, M. Hernandez, J. Mudgett, H. Hassing, C. Burton, S. Mundt, S. Chun, D. Fletcher, D. J. Card, J. Lisnock, et al.
Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice
J. Immunol., September 15, 2000; 165(6): 3430 - 3435.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C.-C. Chan, S. Boyce, C. Brideau, S. Charleson, W. Cromlish, D. Ethier, J. Evans, A. W. Ford-Hutchinson, M. J. Forrest, J. Y. Gauthier, et al.
Rofecoxib [Vioxx, MK-0966; 4-(4'-Methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A Potent and Orally Active Cyclooxygenase-2 Inhibitor. Pharmacological and Biochemical Profiles
J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 551 - 560.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
P. Liu, B. Xu, C. E. Hock, R. Nagele, F. F. Sun, and P. Y-K Wong
NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R
Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2191 - H2198.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. A. Mancini, K. Blood, J. Guay, R. Gordon, D. Claveau, C.-C. Chan, and D. Riendeau
Cloning, Expression, and Up-regulation of Inducible Rat Prostaglandin E Synthase during Lipopolysaccharide-induced Pyresis and Adjuvant-induced Arthritis
J. Biol. Chem., February 2, 2001; 276(6): 4469 - 4475.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.